TAI · 6861.TW
InnoCare Optoelectronics Corporation
NT$213.50-NT$19.00 (-8.17%)
InnoCare Optoelectronics Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.43% below the high.
Loading market information…
TWO · 6649.TWO · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:19 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Taiwan Biomaterial Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.47% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Taiwan Biomaterial Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Taiwan Biomaterial Co., Ltd., established in 2010 and based in Zhubei, Taiwan, focuses on the innovation, development, and commercialization of medical devices throughout Taiwan. Their product offerings include Foamagen, a pioneering dural substitute characterized by its foamy structure. The company also provides a sophisticated negative pressure catheter system engineered for stroke intervention, which efficiently suctions and removes cerebrovascular embolism blood clots, accompanied by a specialized nickel-titanium guidewire essential for guiding intricate neurovascular procedures. Additionally, Taiwan Biomaterial develops advanced tissue repair and regeneration solutions specifically targeting the treatment of early-stage osteoarthritis.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$213.50-NT$19.00 (-8.17%)
InnoCare Optoelectronics Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.43% below the high.
NT$28.40-NT$0.70 (-2.41%)
Applied BioCode Corporation’s quoted price sits in the upper half of its reported 52-week range, 10.97% below the high.
NT$21.00-NT$0.05 (-0.24%)
Maywufa Company Ltd.’s quoted price sits in the upper half of its reported 52-week range, 5.83% below the high.
NT$5.85-NT$0.09 (-1.52%)
Mercury Biopharmaceutical Corporation’s quoted price sits in the lower half of its reported 52-week range, 52.05% below the high.
NT$73.00-NT$1.10 (-1.48%)
A Plus Biotechnology Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 20.65% below the high.
NT$26.40-NT$0.40 (-1.49%)
Taiwan Bio Therapeutics Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 19.76% below the high.
NT$23.35-NT$0.55 (-2.3%)
Wellell Inc.’s quoted price sits in the lower half of its reported 52-week range, 9.85% below the high.
NT$54.70+NT$0.40 (+0.74%)
Dynamic Medical Technologies Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.79% below the high.
